Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Other Non-Current Assets: 2020-2025

Historic Other Non-Current Assets for Foghorn Therapeutics (FHTX) over the last 6 years, with Sep 2025 value amounting to $2.0 million.

  • Foghorn Therapeutics' Other Non-Current Assets rose 17.10% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 17.10%. This contributed to the annual value of $1.7 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Foghorn Therapeutics' Other Non-Current Assets is $2.0 million, which was down 0.00% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Foghorn Therapeutics' Other Non-Current Assets ranged from a high of $2.4 million in Q1 2022 and a low of $1.7 million during Q2 2023.
  • For the 3-year period, Foghorn Therapeutics' Other Non-Current Assets averaged around $1.8 million, with its median value being $1.7 million (2025).
  • As far as peak fluctuations go, Foghorn Therapeutics' Other Non-Current Assets soared by 38.66% in 2022, and later decreased by 28.21% in 2023.
  • Over the past 5 years, Foghorn Therapeutics' Other Non-Current Assets (Quarterly) stood at $2.4 million in 2021, then dropped by 0.88% to $2.4 million in 2022, then decreased by 28.21% to $1.7 million in 2023, then remained steady at $1.7 million in 2024, then increased by 17.10% to $2.0 million in 2025.
  • Its Other Non-Current Assets stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.7 million for Q1 2025.